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Adjuvant treatment of keloid scars: brachytherapy or 
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Purpose/Objective: Evaluation of perioperative treatment of the 
Keloids scars with electron beam therapy or low dose rate 
brachytherapy by Iridium 192. 
Materials and Methods: From 1994 to 2010, 95 patients with 142 
keloids scars have been treated by immediate perioperative 
radiotherapy and retrospectively reviewed in our Institute: 116 scars 
were treated by electron therapy (E-) and 26 by brachytherapy (Ir). 
Results: In group E-: treated locations were: earlobe n = 88 (76%), 
thorax n = 14 (12%), neck n = 9 (8%), limbs n = 5 (4%). The median size 
of lesions was 3 cm (range (R): 0, 5-18 cm). In 95.6% of cases, a dose 
of 15 Gy was delivered in 5 fractions of 3 Gy. The median follow-up 
was 70 months (R: 7-161 months). The 2-year and 5-year local control 
were respectively 69% (95% confidence interval (95% CI): 59-76%) and 
55% (95% CI: 45-64%). 
In group Ir: treated locations were: neck n = 3 (11%), earlobe n = 8 
(32%), abdomen n = 3 (11%), thorax n = 2 (8%), limbs n = 10 (38%). The 
median size of lesions was 6.6 cm (R: 1, 7-28 cm). The median dose 
delivered at 5 mm from the source was 20 Gy (R: 15-20, 69). The 
median follow-up was 113 months (R: 21-219 months). The 2-year and 
5-year local control were respectively 84.6% (95% CI: 64-94%) and 
73.5% (95% CI: 49-87%). There were no cases of radiation-induced 
cancer or unexpected local complications. A trend to a better local 
control with brachytherapy was noted (2-year relative increase of 
15.9% compared to group E-) though this difference did not reach the 
significance (p = 0.099), probably due to the reduced number of 
patients in brachytherapy group. 
Conclusions: Brachytherapy seems to provide better local control 
compared to electron therapy, and should be proposed as first line 
treatment. However, electrontherapy is an interesting alternative in 
case of difficulty to perform brachytherapy. There is probably a dose 
effect: according to published data, 25 to 30 Gy at least should be 
proposed.  
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Purpose/Objective: In recent years, the target form of TBI techniques 
using helical tomotherapy system has been reported from several 
institutions, and these studies have shown the favorable early clinical 
results, and the reduction of acute radiation toxicities. One of the 
radiation sensitive organs is ovary. We experienced the recovery of 
ovarian function and childbirth after conventional TBI technique using 
ovary shielding, previously. In that study, the total dose to ovary was 
estimated about 3.1Gy by the results of measurements for humanoid 
phantom. The purpose of present study is to develop a TBI technique 
using Tomotherapy for preservation of ovarian function. 
Materials and Methods: We used a female patient's CT image set for 
TBI planning that was scanned from the top of skull to the mid-thigh. 
The Tomotherapy TBI plan was generated on the TomoTherapy 
Planning Station Ver.4.2.0.0, using a 2.5cm jaw width and an average 
pitch value of 0.43. We set the target which pulled 2.0 mm from a 
whole body from the head to the upper-femur with the PTV. The 
organs at risk (OARs) included the lungs and ovaries. Contours for 
ovaries were drawn by a radiodiagnosis specialist. The plan had 6 
fractions defined for a planned delivery of 12 Gy, and that was 
prescribed to ensure, at a minimum, 95% planning target volume dose 
coverage with the prescription dose (percentage of PTV receiving dose 
of 12 Gy was 95%). Additionally, for sparing OARs, we designed the 
plan such that Dmax and D50 for lungs-1cm were 8Gy and 4Gy, 
respectively, and Dmax for ovaries was 1.5Gy. 
Results: The Dmax, Dmin, and Dmean for the PTV were 14.6 Gy, 1.3 
Gy, and 12.4 Gy, respectively. The average organ doses were 12 Gy in 
general, except for the doses to the OARs. We succeeded to reduce 
the dose to the OARs. The Dmax, Dmin, and Dmean for the lung was 
13.2 Gy, 3.3 Gy, and 9.1 Gy, respectively, and for the ovaries was 2.5 
Gy, 2.2 Gy, and 2.3 Gy, respectively.  
 
 Conclusions: Our present results suggest that the favorable TBI 
treatments for conserving ovarian function can be planned using 
Tomotherapy technique. 
 
 POSTER: PHYSICS TRACK: BASIC DOSIMETRY AND 
PHANTOM AND DETECTOR DEVELOPMENTS/ 
CHARACTERISATION  
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Purpose/Objective: To demonstrate that µm-scale signal extraction 
from EBT2 film can be used for accurate film calibration and point 
measurement. 
Materials and Methods: Measurements were made using Gafchromic 
EBT2 film in conjunction with the TomoTherapy Hi-Art II system. EBT2 
films were cut to rough squares of approx. 1-2mm. The film 
orientation was demarcated with permanent marker in the corner of 
each piece to allow correct positioning throughout the procedure. A 
film calibration was performed using solid water slabs with an ion 
chamber, and irradiating 6 doses ranging from 15cGy to 400cGy. Each 
dose level was measured with a 5-film sample. An Epson Expression 
10000XL was used for scanning the films. Films were placed within a 
predefined position on the flatbed scanner surface. Scans were 
started 30 minutes after irradiation with a 5-minute scanner warmup 
before each scan session. Images were scanned with a resolution of 
12800 dpi. Five sequential scans were done for every measurement 
and the average of the last three scans was taken as the official 
reading. A square ROI sample of 200x200 pixels (~400x400µm2) was 
used in signal extraction for all film measurements. The mean value 
measured in each 5-film sample was used as a single data point on the 
calibration curve. The corrected ODred signal, as originally suggested 
by the manufacturer1, was used to correlate to the measured doses. 
The calibration curve data was fit using the rational function 
y(x)=(a+cx)/(1+bx). The dosimetry method was verified with a set of 
10 absolute dose point measurements using an open-field irradiation 
on a phantom. The film results were compared to the ion chamber 
measurements and TPS calculation. 
 
  
Results: The coefficient of determination, r2, measured 0.99997 for 
the calibration curve fit and the local residuals measured less than 
0.5% for doses greater than or equal to 1Gy. The largest local residual 
was 5% (0.7cGy) and was observed at a dose level of 15cGy. The 
verification set measured a mean dose of 193.4cGy (σ=1.4cGy) while 
the ion chamber measured an absolute dose of 190.7cGy and the TPS 
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calculated 191.7cGy. The error in film measurement increases from 
1.4cGy to 2.2cGy if a single film is used instead of a 5-film sample. 
Conclusions: Submillimeter point dose measurement with EBT2 film is 
shown to be very accurate. Signal extraction from such a small spatial 
area allows for accurate measurement in small-fields, steep dose 
gradients, and non-flattened beams.  
References: 
1. Gafchromic EBT2 Self-Developing Film for Radiotherapy Dosimetry, 
ISP White Paper, Revision 1, February, 2009. 
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Purpose/Objective: An optical fibre sensor for use in radiotherapy 
dosimetry is presented. The sensor is based on a scintillating material 
coated plastic optical fibre (POF), which emits visible light when 
exposed to low level ionising radiation. The incident level of ionising 
radiation can be determined by analysing the observed emission 
spectra. The work presented reports on the design of the sensor and 
the stability of the sensor during measurement of incident x-ray 
energy. Initial testing of the sensor on a Linac is presented, 
demonstrating the suitability of such a sensor for a range of 
radiotherapy dosimetry applications, including the area of small field 
dosimetry. 
Materials and Methods: A 1 metre PMMA (Polymethyl Methacrylate) 
plastic optical fibre of 1mm diameter is prepared.The optical fibre 
cable end was polished, an epoxy resin and hardener mix,containing 
the scintillation material, was then encapsulated around the fibre 
cable end using an injection method and allowed to set. The radiation 
source used was a Siemens Artiste, with a water equivalent phantom 
of varying depths. The sensor was connected to a fluorescent 
spectrometer using a 19 meter long POF cable. The spectrometer and 
a computer for analysing the resultant optical signal were located at 
the control console. The optical fibre coated with a scintillation 
material fluoresces when subjected to ionising radiation. Upon 
scintillation, the low level light permeates the fibre optic cable end 
and the spectrometer placed at the distal end of the POF cable 
measures the received optical signal. The amount of radiation 
incident on the sensor is directly related to the measured intensity of 
the received spectrum at the preselected wavelengths. The 
spectrometer detects and records low level light from the sensor and 
detects any changes in optical intensity levels that are recorded via 
LabVIEW software. 
 
 Results: The optical fibre sensor was initially tested for its response 
to 100MU (Monitor Units,where 1MU = 1cGy when SSD (surface to 
source distance) is 100cm at a depth of Dmax.) at 6MV photon energy 
using a 1.5cm build-up. The peak intensity of the received fluorescent 
signal, at 544nm, was monitored. During irradiation the sensor 
demonstrates a stable response and then returns to its original off 
state when the radiation stops. The sensor was then tested at 
repeated radiation doses of 100MU at 15MV to test for the stability of 
the optical fibre sensor at repeated exposures. 
 
  
Conclusions: The optical fibre sensor was investigated for its response 
to known incident radiation exposure patterns, repeatability and 
stability of measurement. The sensor demonstrated excellent 
response to a wide range of exposure conditions including different 
levels of ionising energy, dose rates and exposure duration. The 
results show that the sensor is capable of realtime, accurate and 
repeatable radiation dose measurements with a maximum variance of 
± 2% from a Linac. 
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Purpose/Objective: Radiochromic films such as Gafchromic EBT or 
EBT2 offer an excellent spatial resolution which is beneficial for dose 
verification in highly conformal radiation therapy such as IMRT or 
proton therapy. Recently, a new generation of these films, EBT3, has 
become available. As composition and thickness of the sensitive layer 
are the same as for the previous EBT2 films, a similar dosimetric 
performance is expected, in particular with respect to the known 
energy dependence of the films. The side orientation dependence, 
which is reported for EBT2 films, has been eliminated in EBT3 films by 
a symmetric layer configuration.  
Materials and Methods: The general EBT3 film characteristics such as 
read-out orientation dependence and post-exposure darkening growth 
are evaluated and compared to EBT2 films. Film response has been 
investigated in clinical photon and proton beams. The energy 
dependence of both, EBT2 and EBT3 films, has been studied for low 
proton energies (<=20MeV) as predominating in the vicinity of the 
Bragg peak but also up to a maximum energy of 200 MeV. 
Results: In general, EBT3 show a comparable performance to EBT2 
films, moreover, orientation dependence with respect to film side is 
completely eliminated in EBT3 films. Response differences of EBT2and 
EBT3 films are of the same order of magnitude as batch-to-batch 
variations observed for EBT2 films. Photon and proton exposure show 
similar response for both generations of EBT films. Depth dose 
measurements show an under-estimation of dose by up to 20 % in the 
Bragg peak region for both types of film.  
Conclusions: EBT3 and its precursor EBT2 have similar dosimetric 
performance and can, thus, be applied to dose verification in IMRT in 
the same way. Dose under-response in the Bragg peak region has to be 
taken into account if films are to be applied for dose verification in 
proton therapy.  
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Purpose/Objective: In the radiotherapy Treatment Planning Systems 
(TPS) various calculation algorithms are used (Pencil Beam 
Convolution PBC, analytical anisotropic algorithm AAA, Monte-Carlo). 
The accuracy of dose calculations has to be verified. Numerous 
phantom types and detectors are proposed to verify the TPS 
calculations by dosimetric measurements. A heterogeneous cubic-
shape phantom has been designed for this purpose within a 
Coordinated Research Project of the IAEA. 
